Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | SLC5A2 | P31639 | 3/20 | 0.50 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.50 |
| ▸ | TYR | P14679 | 2/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29366465 | 1.00 | MAOB (0.55) | MAOBSLC5A2SLC5A1TYRPTPN1 | |
| SCHEMBL29193260 | 0.88 | SLC5A2 (0.56) | SLC5A2SLC5A1TYRPTPN1 | |
| SCHEMBL23591178 | 0.87 | MAOB (0.53) | MAOBTYRSLC28A3 | |
| SCHEMBL7998325 | 0.85 | MAOB (0.70) | MAOBSLC5A2SLC5A1 | |
| SCHEMBL3636327 | 0.85 | MAOB (0.70) | MAOBSLC5A2SLC5A1 | |
| SCHEMBL8818263 | 0.85 | MAOB (0.70) | MAOBSLC5A2SLC5A1 | |
| SCHEMBL4453793 | 0.85 | MAOB (0.70) | MAOBSLC5A2SLC5A1 | |
| SCHEMBL8843011 | 0.85 | MAOB (0.70) | MAOBSLC5A2SLC5A1 | |
| SCHEMBL3636329 | 0.85 | MAOB (0.70) | MAOBSLC5A2SLC5A1 | |
| SCHEMBL12812271 | 0.85 | MAOB (0.70) | MAOBSLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114381484-B | Application of UGT85A1 or RrUGT3 in catalyzing various substrates to generate glycoside compounds | 山东大学 | 2024-04-19 | — | — | CN | claimed |
| CN-113980071-A | Salidroside derivatives and application thereof | 重庆大学 | 2022-01-28 | — | — | CN | disclosed |
| WO-2011023713-A2 | SALIDROSIDE FOR THE PHARMACOLOGICAL TREATMENT OF BULIMIA NERVOSA AND BINGE EATING DISORDER (BED) | MASSI MAURIZIO (IT) | 2011-03-03 | — | — | WO | disclosed |